Never Run Out Of Buyers To Sell To.

Alia Therapeutics is a biotechnology company dedicated to developing next-generation gene editing therapies for Inherited Retinal Diseases, starting with Retinitis Pigmentosa a leading cause of inherited blindness worldwide. IRDs are marked by extreme genetic and clinical heterogeneity, making traditional therapeutic approaches difficult to scale and leaving many patients without viable treatment options. Alia addresses this challenge through a modular, mutation-agnostic approach enabled by its proprietary CRISPR platform. At the core of Alia’s technology are novel, next-generation CRISPR…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.